Atrys reports H1 2026 revenue up 9.4% and EBITDA up 21.3%
Atrys Health reported H1 2026 revenue of €77.7M, up 9.4%, with EBITDA up 21.3%. The company said net debt fell 79.2% after the ASPY sale and that full-year guidance was reaffirmed.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.